Clinical Trials Directory

Trials / Unknown

UnknownNCT03960671

Therapeutic Drug Monitoring of Anxiolytics in Children

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
Wei Zhao · Academic / Other
Sex
All
Age
29 Days – 18 Years
Healthy volunteers
Not accepted

Summary

In this study, the therapeutic drug monitoring of anxiolytics is carried out among children to obtain the drug concentration, clinical efficacy and safety data of children patients in different gender and age groups. Then the investigators analyze the relationship between blood drug concentration and efficacy and safety, and provide recommendations for the treatment window of anxiolytics in Chinese children.

Conditions

Interventions

TypeNameDescription
DRUGMidazolam/diazepam/propofolTherapeutic drug monitoring of anxiolytics

Timeline

Start date
2018-08-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2019-05-23
Last updated
2019-05-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03960671. Inclusion in this directory is not an endorsement.

Therapeutic Drug Monitoring of Anxiolytics in Children (NCT03960671) · Clinical Trials Directory